COMMUNIQUÉ RÉGLEMENTÉ
News
-
-
COMMUNIQUÉ RÉGLEMENTÉ
BIOPHYTIS ANNOUNCES THE AUDITING OF ITS 2025 FINANCIAL STATEMENTS AND THE RESUMPTION OF TRADING IN ITS STOCK
Biophytis announces the auditing of its 2025 financial statements and the resumption of trading in its stock. The company's financial debt and current liabilities decreased by 5% compared to 2024 -
COMMUNIQUÉ DE PRESSE
Biophytis annonce la publication de ses comptes annuels 2025 et la reprise de la cotation de son action
Biophytis annonce la publication de ses comptes annuels 2025 et la reprise de la cotation de son action sur Euronext Growth Paris. Les résultats financiers et opérationnels sont présentés ainsi que la situation de trésorerie -
COMMUNIQUÉ DE PRESSE
BIOPHYTIS ANNOUNCES THE AUDITING OF ITS 2025 FINANCIAL STATEMENTS AND THE RESUMPTION OF TRADING IN ITS STOCK
Biophytis announces the auditing of its 2025 financial statements and the resumption of trading in its stock. The company's financial debt and current liabilities decreased by 5% in 2025. Net loss improved by 13% compared to 2024 -
-
-
COMMUNIQUÉ RÉGLEMENTÉ
BIOPHYTIS REPORTS ITS PROVISIONAL FINANCIAL RESULTS AND PROVIDES ITS STRATEGIC OUTLOOK
Biophytis reports provisional financial results for fiscal year 2025 and strategic outlook, including milestones in sarcopenia and obesity programs, engagement with scientific community, and financial restructuring -
-
-
